Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nilotinib Effect on Metformin PK/PD in Healthy Males
NCT04448821Phase 1Completed
- Sponsor
- Hyewon Chung
- Start
- Jul 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of nilotinib and metformin (2 arms), sponsored by Hyewon Chung. Primary endpoints: Maximum Observed Plasma Concentration, Area Under the Plasma Concentration-Time Curve from Time Zero to Infinity and 2 more. Started Jul 2020; status: completed.
02
Drugs
nilotinibmetformin
Beyond the preview
Go deeper on NCT04448821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04448821.